578 related articles for article (PubMed ID: 30136921)
41. Optimal use of plasma and urine BK viral loads for screening and predicting BK nephropathy.
Boan P; Hewison C; Swaminathan R; Irish A; Warr K; Sinniah R; Pryce TM; Flexman J
BMC Infect Dis; 2016 Jul; 16():342. PubMed ID: 27448566
[TBL] [Abstract][Full Text] [Related]
42. Comparative evaluation of laboratory developed real-time PCR assays and RealStar(®) BKV PCR Kit for quantitative detection of BK polyomavirus.
Hasan MR; Tan R; Al-Rawahi G; Thomas E; Tilley P
J Virol Methods; 2016 Aug; 234():80-6. PubMed ID: 27091098
[TBL] [Abstract][Full Text] [Related]
43. Early BK polyomavirus (BKV) reactivation in donor kidney is a risk factor for development of BKV-associated nephropathy.
Saundh BK; Baker R; Harris M; Welberry Smith MP; Cherukuri A; Hale A
J Infect Dis; 2013 Jan; 207(1):137-41. PubMed ID: 23100561
[TBL] [Abstract][Full Text] [Related]
44. Torquetenovirus viremia for early prediction of graft rejection after kidney transplantation.
Solis M; Velay A; Gantner P; Bausson J; Filipputtu A; Freitag R; Moulin B; Caillard S; Fafi-Kremer S
J Infect; 2019 Jul; 79(1):56-60. PubMed ID: 31100359
[TBL] [Abstract][Full Text] [Related]
45. Urinary exosomal viral microRNA as a marker of BK virus nephropathy in kidney transplant recipients.
Kim MH; Lee YH; Seo JW; Moon H; Kim JS; Kim YG; Jeong KH; Moon JY; Lee TW; Ihm CG; Kim CD; Park JB; Chung BH; Kim YH; Lee SH
PLoS One; 2017; 12(12):e0190068. PubMed ID: 29267352
[TBL] [Abstract][Full Text] [Related]
46. Currently recommended BK virus (BKV) plasma viral load cutoff of ≥4 log10/mL underestimates the diagnosis of BKV-associated nephropathy: a single transplant center experience.
Hassan S; Mittal C; Amer S; Khalid F; Patel A; Delbusto R; Samuel L; Alangaden G; Ramesh M
Transpl Infect Dis; 2014 Feb; 16(1):55-60. PubMed ID: 24283677
[TBL] [Abstract][Full Text] [Related]
47. BK virus replication in renal transplant recipients: Analysis of potential risk factors may contribute in reactivation.
Shenagari M; Monfared A; Eghtedari H; Pourkazemi A; Hasandokht T; Khosravi M; Asharfkhani B
J Clin Virol; 2017 Nov; 96():7-11. PubMed ID: 28915452
[TBL] [Abstract][Full Text] [Related]
48. Monitoring of polyomavirus BK replication and impact of preemptive immunosuppression reduction in renal-transplant recipients in China: a 5-year single-center analysis.
Huang G; Wang CX; Zhang L; Fei JG; Deng SX; Qiu J; Li J; Chen GD; Fu Q; Chen LZ
Diagn Microbiol Infect Dis; 2015 Jan; 81(1):21-6. PubMed ID: 25445121
[TBL] [Abstract][Full Text] [Related]
49. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients.
Hirsch HH; Knowles W; Dickenmann M; Passweg J; Klimkait T; Mihatsch MJ; Steiger J
N Engl J Med; 2002 Aug; 347(7):488-96. PubMed ID: 12181403
[TBL] [Abstract][Full Text] [Related]
50. Polyomavirus BK versus JC replication and nephropathy in renal transplant recipients: a prospective evaluation.
Drachenberg CB; Hirsch HH; Papadimitriou JC; Gosert R; Wali RK; Munivenkatappa R; Nogueira J; Cangro CB; Haririan A; Mendley S; Ramos E
Transplantation; 2007 Aug; 84(3):323-30. PubMed ID: 17700156
[TBL] [Abstract][Full Text] [Related]
51. A prospective cross-sectional study of BK virus infection in non-renal solid organ transplant recipients with chronic renal dysfunction.
Barton TD; Blumberg EA; Doyle A; Ahya VN; Ferrenberg JM; Brozena SC; Limaye AP
Transpl Infect Dis; 2006 Jun; 8(2):102-7. PubMed ID: 16734633
[TBL] [Abstract][Full Text] [Related]
52. Mutations in the BC-loop of the BKV VP1 region do not influence viral load in renal transplant patients.
Krautkrämer E; Klein TM; Sommerer C; Schnitzler P; Zeier M
J Med Virol; 2009 Jan; 81(1):75-81. PubMed ID: 19031459
[TBL] [Abstract][Full Text] [Related]
53. Prospective monitoring of BK virus reactivation in renal transplant recipients in North India.
Thakur R; Arora S; Nada R; Minz M; Joshi K
Transpl Infect Dis; 2011 Dec; 13(6):575-83. PubMed ID: 21507160
[TBL] [Abstract][Full Text] [Related]
54. Risk factors for BK virus infection in living-donor renal transplant recipients: a single-center study from China.
Li P; Cheng D; Wen J; Xie K; Li X; Ni X; Ji S; Chen J
Ren Fail; 2018 Nov; 40(1):442-446. PubMed ID: 30052479
[TBL] [Abstract][Full Text] [Related]
55. Role of BK virus infection in end-stage renal disease patients waiting for kidney transplantation--viral replication dynamics from pre- to post-transplant.
Mitterhofer AP; Tinti F; Pietropaolo V; Umbro I; Anzivino E; Bellizzi A; Zavatto A; Poli L; Berloco PB; Taliani G
Clin Transplant; 2014 Mar; 28(3):299-306. PubMed ID: 24506672
[TBL] [Abstract][Full Text] [Related]
56. A comparative study of BK and JC virus infections in organ transplant recipients.
Randhawa P; Uhrmacher J; Pasculle W; Vats A; Shapiro R; Eghtsead B; Weck K
J Med Virol; 2005 Oct; 77(2):238-43. PubMed ID: 16121361
[TBL] [Abstract][Full Text] [Related]
57. Cross-sectional study of BK virus infection in pediatric kidney transplant recipients.
Fogeda M; Muñoz P; Luque A; Morales MD; Bouza E;
Pediatr Transplant; 2007 Jun; 11(4):394-401. PubMed ID: 17493219
[TBL] [Abstract][Full Text] [Related]
58. Rapid dynamics of polyomavirus type BK in renal transplant recipients.
Funk GA; Steiger J; Hirsch HH
J Infect Dis; 2006 Jan; 193(1):80-7. PubMed ID: 16323135
[TBL] [Abstract][Full Text] [Related]
59. Prevalence and subtypes of BK virus in pediatric renal transplant recipients in Russia.
Momynaliev KT; Gorbatenko EV; Shevtsov AB; Gribanov OG; Babenko NN; Kaabak MM
Pediatr Transplant; 2012 Mar; 16(2):151-9. PubMed ID: 22300090
[TBL] [Abstract][Full Text] [Related]
60. Viral Origin, Clinical Course, and Renal Outcomes in Patients With BK Virus Infection After Living-Donor Renal Transplantation.
Schwarz A; Linnenweber-Held S; Heim A; Framke T; Haller H; Schmitt C
Transplantation; 2016 Apr; 100(4):844-53. PubMed ID: 26720302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]